Chemical Synthesis of Novel DDR1 Inhibitors and Their Activity Against Gefitinib-Resistant Non-Small Cell Lung Cancer

被引：0
|
作者：
Xuemei Xu [1 ]
Siyu Chen [2 ]
Doudou Sun [2 ]
Xuebao Wang [2 ]
Zhouyang Xu [2 ]
机构：
[1] Department of Pharmacy,
[2] Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine,undefined
[3] Wenzhou,undefined
[4] School of Pharmaceutical Science,undefined
[5] Wenzhou Medical University,undefined
[6] Wenzhou,undefined
来源：
Russian Journal of Bioorganic Chemistry | 2025年 / 51卷 / 1期
关键词：
non-small cell lung cancer; DDR1 inhibitor; gefitinib resistance; antitumor activity;
D O I：
10.1134/S1068162025010108
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：285 / 297
页数：12
相关论文
共 50 条
  • [1] Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer
    Makoto Sudo
    Tan Min Chin
    Seiichi Mori
    Ngan B. Doan
    Jonathan W. Said
    Makoto Akashi
    H. Phillip Koeffler
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1325 - 1334
  • [2] Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer
    Sudo, Makoto
    Chin, Tan Min
    Mori, Seiichi
    Doan, Ngan B.
    Said, Jonathan W.
    Akashi, Makoto
    Koeffler, H. Phillip
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (05) : 1325 - 1334
  • [3] Implications of MicroRNAs in the Treatment of Gefitinib-Resistant Non-Small Cell Lung Cancer
    Sin, Thomas K.
    Wang, Fengfeng
    Meng, Fei
    Wong, S. C. Cesar
    Cho, William C. S.
    Siu, Parco M.
    Chan, Lawrence W. C.
    Yung, Benjamin Y. M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (02)
  • [4] Inhibition of DDR1 promotes ferroptosis and overcomes gefitinib resistance in non-small cell lung cancer
    Zhang, Yuan
    Qian, Jinheng
    Fu, Yanneng
    Wang, Zihan
    Hu, Wanping
    Zhang, Jinxia
    Wang, Yuexuan
    Guo, Yangyang
    Chen, Weikang
    Zhang, Yejun
    Wang, Xuebao
    Xie, Zixin
    Ye, Hui
    Ye, Faqing
    Zuo, Zhigui
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2024, 1870 (07):
  • [5] Synthesis of Flavokawain B and its Anti-proliferative Activity Against Gefitinib-resistant Non-small Cell Lung Cancer (NSCLC)
    Seo, Young Ho
    Oh, Yong Jin
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2013, 34 (12): : 3782 - 3786
  • [6] Effect of opioid receptor agonists in gefitinib-resistant non-small cell lung cancer
    Suzuki, Atsuo
    Kuzumaki, Naoko
    Hosoya, Takahiro
    Narita, Michiko
    Tsukiji, Kozue
    Suzuki, Masami
    Uezono, Yasuhito
    Morita, Hiroshi
    Suzuki, Tsutomu
    Narita, Minoru
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 105P - 105P
  • [7] Dominant FGF Autocrine Signaling in Gefitinib-Resistant Non-Small Cell Lung Cancer Cells
    Heasley, Lynn E.
    Marek, Lindsay
    Fritzsche, Alexa
    Helton, Wallace R.
    Nemenoff, Raphael A.
    McDermott, Lee A.
    Helfrich, Barbara
    Bunn, Paul A.
    FASEB JOURNAL, 2008, 22
  • [8] In Vitro and in Vivo Efficacy of NBDHEX on Gefitinib-resistant Human Non-small Cell Lung Cancer
    Sha, Huanhuan
    Dong, Shuchen
    Yu, Chen
    Zou, Renrui
    Zhu, Yue
    Lu, Ya
    Zhang, Junying
    Cao, Haixia
    Chen, Dan
    Wu, Jianzhong
    Feng, Jifeng
    JOURNAL OF CANCER, 2020, 11 (24): : 7216 - 7223
  • [9] Potential roles of tumor microenvironment in gefitinib-resistant non-small cell lung cancer: A narrative review
    Chen, Mu-Tong
    Li, Bai-Zhi
    Zhang, En-Pu
    Zheng, Qing
    MEDICINE, 2023, 102 (40) : E35086
  • [10] Discovery of hybrid Hsp90 inhibitors and their anti-neoplastic effects against gefitinib-resistant non-small cell lung cancer (NSCLC)
    Jeong, Chul-Ho
    Park, Hee Baek
    Jang, Won Jun
    Jung, Su Hyun
    Seo, Young Ho
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (01) : 224 - 227
12345